| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 30 | 2022 | 205 | 7.980 |
Why?
|
| Induced Pluripotent Stem Cells | 23 | 2022 | 86 | 7.950 |
Why?
|
| Cell Differentiation | 42 | 2022 | 1034 | 5.170 |
Why?
|
| Liver | 35 | 2020 | 1118 | 4.720 |
Why?
|
| Pluripotent Stem Cells | 13 | 2019 | 42 | 3.350 |
Why?
|
| Gene Expression Regulation, Developmental | 23 | 2017 | 328 | 2.860 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 21 | 2017 | 28 | 2.520 |
Why?
|
| Transcription Factors | 24 | 2014 | 753 | 2.240 |
Why?
|
| GATA6 Transcription Factor | 11 | 2021 | 27 | 2.230 |
Why?
|
| DNA-Binding Proteins | 22 | 2014 | 700 | 1.950 |
Why?
|
| GATA4 Transcription Factor | 14 | 2013 | 33 | 1.930 |
Why?
|
| Endoderm | 14 | 2017 | 37 | 1.700 |
Why?
|
| Embryonic Stem Cells | 11 | 2015 | 40 | 1.650 |
Why?
|
| Mice | 72 | 2022 | 8472 | 1.650 |
Why?
|
| Phosphoproteins | 13 | 2005 | 202 | 1.570 |
Why?
|
| Chromatin | 2 | 2021 | 76 | 1.510 |
Why?
|
| Liver Diseases | 2 | 2022 | 193 | 1.310 |
Why?
|
| Animals | 80 | 2022 | 20877 | 1.300 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 6 | 2020 | 8 | 1.020 |
Why?
|
| Hypercholesterolemia | 2 | 2017 | 86 | 1.000 |
Why?
|
| Drug Discovery | 3 | 2022 | 94 | 0.940 |
Why?
|
| Cadherins | 5 | 2013 | 93 | 0.860 |
Why?
|
| NAD | 2 | 2022 | 73 | 0.840 |
Why?
|
| Small Molecule Libraries | 3 | 2017 | 53 | 0.830 |
Why?
|
| Heart | 9 | 2013 | 850 | 0.830 |
Why?
|
| Mutation | 8 | 2020 | 1213 | 0.830 |
Why?
|
| Transcription, Genetic | 10 | 2012 | 562 | 0.820 |
Why?
|
| Gene Expression Regulation | 12 | 2014 | 1293 | 0.780 |
Why?
|
| Methylmalonyl-CoA Decarboxylase | 1 | 2020 | 2 | 0.770 |
Why?
|
| Propionic Acidemia | 1 | 2020 | 2 | 0.770 |
Why?
|
| Membrane Glycoproteins | 5 | 2017 | 370 | 0.740 |
Why?
|
| Stem Cells | 9 | 2005 | 248 | 0.740 |
Why?
|
| Myocytes, Cardiac | 7 | 2017 | 442 | 0.710 |
Why?
|
| Embryo, Mammalian | 10 | 2012 | 176 | 0.700 |
Why?
|
| Cell Culture Techniques | 4 | 2015 | 189 | 0.680 |
Why?
|
| Cell Lineage | 3 | 2016 | 146 | 0.670 |
Why?
|
| Models, Biological | 5 | 2019 | 981 | 0.670 |
Why?
|
| Humans | 57 | 2022 | 68525 | 0.660 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 84 | 0.650 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2017 | 19 | 0.620 |
Why?
|
| Gene Expression | 8 | 2014 | 770 | 0.620 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2012 | 39 | 0.620 |
Why?
|
| Mice, Transgenic | 13 | 2013 | 1032 | 0.620 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2015 | 710 | 0.610 |
Why?
|
| Proteomics | 3 | 2017 | 246 | 0.610 |
Why?
|
| High-Throughput Screening Assays | 2 | 2017 | 48 | 0.610 |
Why?
|
| Cardiac Glycosides | 1 | 2017 | 8 | 0.610 |
Why?
|
| Mice, Knockout | 18 | 2012 | 1692 | 0.610 |
Why?
|
| Cells, Cultured | 15 | 2017 | 2673 | 0.610 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2017 | 46 | 0.590 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 137 | 0.580 |
Why?
|
| Multipotent Stem Cells | 1 | 2016 | 6 | 0.580 |
Why?
|
| Prisoners | 3 | 2007 | 50 | 0.580 |
Why?
|
| Regenerative Medicine | 2 | 2013 | 17 | 0.580 |
Why?
|
| Pancreas | 5 | 2012 | 225 | 0.580 |
Why?
|
| Cell Line | 16 | 2020 | 1752 | 0.570 |
Why?
|
| Teratoma | 2 | 2015 | 22 | 0.570 |
Why?
|
| Proteins | 4 | 2007 | 473 | 0.570 |
Why?
|
| Carrier Proteins | 2 | 2017 | 597 | 0.550 |
Why?
|
| Proteome | 1 | 2016 | 87 | 0.550 |
Why?
|
| Vitronectin | 1 | 2015 | 12 | 0.550 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 48 | 0.540 |
Why?
|
| Cell Adhesion Molecules | 2 | 2007 | 199 | 0.540 |
Why?
|
| Embryonic Structures | 2 | 2005 | 3 | 0.530 |
Why?
|
| Nuclear Proteins | 8 | 2005 | 271 | 0.520 |
Why?
|
| Cellular Reprogramming | 2 | 2015 | 22 | 0.510 |
Why?
|
| Gene Targeting | 6 | 2006 | 58 | 0.500 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 742 | 0.500 |
Why?
|
| Aneuploidy | 1 | 2014 | 21 | 0.500 |
Why?
|
| Endoplasmic Reticulum | 3 | 2012 | 148 | 0.490 |
Why?
|
| Transgenes | 3 | 2002 | 92 | 0.460 |
Why?
|
| Phenotype | 9 | 2017 | 946 | 0.440 |
Why?
|
| Myocardium | 9 | 2013 | 1204 | 0.440 |
Why?
|
| Receptors, LDL | 1 | 2012 | 72 | 0.430 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 10 | 2004 | 24 | 0.410 |
Why?
|
| Serum Response Factor | 2 | 2009 | 15 | 0.410 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 334 | 0.400 |
Why?
|
| Zebrafish Proteins | 2 | 2002 | 100 | 0.390 |
Why?
|
| Antisocial Personality Disorder | 2 | 2007 | 30 | 0.390 |
Why?
|
| Zinc Fingers | 2 | 2008 | 17 | 0.390 |
Why?
|
| Cell Division | 6 | 2014 | 541 | 0.390 |
Why?
|
| Acute-Phase Proteins | 2 | 2008 | 13 | 0.380 |
Why?
|
| RNA, Messenger | 11 | 2015 | 1663 | 0.380 |
Why?
|
| Stress, Physiological | 4 | 2017 | 215 | 0.380 |
Why?
|
| Organogenesis | 3 | 2020 | 49 | 0.370 |
Why?
|
| Glucose | 5 | 2018 | 307 | 0.370 |
Why?
|
| Lipoproteins, LDL | 1 | 2012 | 343 | 0.370 |
Why?
|
| Pericardium | 3 | 2013 | 97 | 0.370 |
Why?
|
| Morphogenesis | 5 | 2004 | 158 | 0.360 |
Why?
|
| DNA | 3 | 2010 | 597 | 0.360 |
Why?
|
| Jejunum | 2 | 2011 | 26 | 0.360 |
Why?
|
| Genes, Lethal | 3 | 2006 | 16 | 0.360 |
Why?
|
| Intestinal Absorption | 2 | 2011 | 41 | 0.360 |
Why?
|
| Personality Inventory | 2 | 2007 | 196 | 0.350 |
Why?
|
| Body Size | 1 | 2009 | 39 | 0.350 |
Why?
|
| Base Sequence | 11 | 2018 | 1015 | 0.340 |
Why?
|
| Embryonic and Fetal Development | 7 | 2001 | 74 | 0.330 |
Why?
|
| Bile Canaliculi | 1 | 2007 | 1 | 0.310 |
Why?
|
| Epithelial Cells | 3 | 2012 | 431 | 0.310 |
Why?
|
| Apolipoproteins B | 2 | 2017 | 29 | 0.310 |
Why?
|
| Immunoglobulins | 1 | 2007 | 97 | 0.300 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 1174 | 0.290 |
Why?
|
| Malingering | 2 | 2008 | 36 | 0.290 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 114 | 0.280 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 248 | 0.280 |
Why?
|
| Cholesterol, LDL | 3 | 2017 | 161 | 0.270 |
Why?
|
| Trans-Activators | 4 | 2007 | 237 | 0.270 |
Why?
|
| Colon | 1 | 2006 | 168 | 0.260 |
Why?
|
| Vaccinia virus | 4 | 1999 | 97 | 0.260 |
Why?
|
| Cell Proliferation | 7 | 2013 | 1173 | 0.260 |
Why?
|
| Organ Specificity | 4 | 2017 | 167 | 0.250 |
Why?
|
| Triglycerides | 5 | 2017 | 184 | 0.250 |
Why?
|
| Laminin | 2 | 2015 | 62 | 0.250 |
Why?
|
| Polyploidy | 2 | 2001 | 24 | 0.250 |
Why?
|
| Proteoglycans | 2 | 2015 | 103 | 0.240 |
Why?
|
| Drug Combinations | 2 | 2015 | 304 | 0.240 |
Why?
|
| Exons | 2 | 2020 | 122 | 0.240 |
Why?
|
| Psychometrics | 2 | 2007 | 514 | 0.240 |
Why?
|
| Recombination, Genetic | 5 | 2006 | 62 | 0.230 |
Why?
|
| Integrases | 4 | 2006 | 31 | 0.230 |
Why?
|
| Cell Nucleolus | 1 | 2002 | 14 | 0.220 |
Why?
|
| Male | 17 | 2020 | 37281 | 0.220 |
Why?
|
| In Situ Hybridization | 4 | 2008 | 201 | 0.220 |
Why?
|
| Ribosomes | 1 | 2002 | 23 | 0.220 |
Why?
|
| Ureter | 1 | 2022 | 16 | 0.220 |
Why?
|
| Gene Dosage | 2 | 2001 | 47 | 0.220 |
Why?
|
| Wechsler Scales | 1 | 2002 | 15 | 0.210 |
Why?
|
| Alleles | 3 | 2012 | 386 | 0.210 |
Why?
|
| Biomarkers | 3 | 2016 | 1593 | 0.210 |
Why?
|
| Hematopoiesis | 2 | 2014 | 108 | 0.210 |
Why?
|
| Gastrula | 4 | 2000 | 17 | 0.210 |
Why?
|
| Viral Proteins | 4 | 2006 | 149 | 0.210 |
Why?
|
| Forensic Psychiatry | 1 | 2002 | 36 | 0.210 |
Why?
|
| Selection, Genetic | 1 | 2001 | 49 | 0.210 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 163 | 0.200 |
Why?
|
| Genetic Markers | 2 | 2001 | 144 | 0.200 |
Why?
|
| Mutagenesis, Insertional | 1 | 2001 | 24 | 0.200 |
Why?
|
| Glycolysis | 2 | 2018 | 79 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2014 | 376 | 0.200 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2001 | 43 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2015 | 489 | 0.200 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 314 | 0.200 |
Why?
|
| Collagen | 2 | 2015 | 636 | 0.200 |
Why?
|
| Genome | 1 | 2001 | 54 | 0.200 |
Why?
|
| Cell Nucleus | 3 | 2007 | 305 | 0.190 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2018 | 51 | 0.190 |
Why?
|
| Cell Adhesion | 2 | 2015 | 324 | 0.180 |
Why?
|
| Intestine, Small | 2 | 2011 | 89 | 0.170 |
Why?
|
| Ribonucleotide Reductases | 1 | 2018 | 9 | 0.170 |
Why?
|
| Cell Respiration | 1 | 2018 | 47 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 2790 | 0.170 |
Why?
|
| Female | 16 | 2018 | 38015 | 0.160 |
Why?
|
| Syndrome | 1 | 2018 | 255 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2019 | 172 | 0.160 |
Why?
|
| Molecular Sequence Data | 9 | 2007 | 1446 | 0.160 |
Why?
|
| Fibroblasts | 3 | 2012 | 902 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 7 | 2009 | 614 | 0.160 |
Why?
|
| Homozygote | 2 | 2017 | 119 | 0.160 |
Why?
|
| Gene Deletion | 4 | 2010 | 235 | 0.160 |
Why?
|
| Signal Transduction | 9 | 2013 | 2688 | 0.150 |
Why?
|
| Mitochondria | 2 | 2022 | 643 | 0.150 |
Why?
|
| Cell Cycle Proteins | 3 | 2007 | 230 | 0.150 |
Why?
|
| RNA-Binding Proteins | 3 | 2007 | 215 | 0.150 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2017 | 13 | 0.150 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 219 | 0.150 |
Why?
|
| Protein Denaturation | 1 | 2017 | 27 | 0.150 |
Why?
|
| Half-Life | 1 | 2017 | 96 | 0.150 |
Why?
|
| Cardiomegaly | 2 | 2010 | 213 | 0.150 |
Why?
|
| Gastric Mucosa | 2 | 2008 | 77 | 0.150 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 68 | 0.150 |
Why?
|
| Viscera | 1 | 1997 | 16 | 0.150 |
Why?
|
| Coronary Vessels | 2 | 2013 | 313 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 200 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2017 | 59 | 0.150 |
Why?
|
| Transfection | 3 | 2010 | 782 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 785 | 0.150 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 138 | 0.150 |
Why?
|
| Proteolysis | 1 | 2017 | 97 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 113 | 0.140 |
Why?
|
| Hypolipidemic Agents | 1 | 2017 | 82 | 0.140 |
Why?
|
| Genotype | 6 | 2013 | 785 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2015 | 954 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2017 | 220 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2016 | 218 | 0.140 |
Why?
|
| Immunomagnetic Separation | 1 | 2015 | 5 | 0.140 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 2550 | 0.140 |
Why?
|
| Insulin | 4 | 2012 | 617 | 0.140 |
Why?
|
| MMPI | 2 | 2008 | 40 | 0.140 |
Why?
|
| Digestive System | 2 | 1997 | 35 | 0.140 |
Why?
|
| Genes, Viral | 2 | 1992 | 44 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2012 | 238 | 0.130 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 240 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 114 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 57 | 0.130 |
Why?
|
| Lipids | 1 | 2017 | 298 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2015 | 238 | 0.130 |
Why?
|
| Virus Replication | 2 | 1992 | 104 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 209 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 2 | 2007 | 164 | 0.130 |
Why?
|
| Lentivirus | 2 | 2011 | 35 | 0.130 |
Why?
|
| Karyotype | 1 | 2014 | 7 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 214 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2453 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2006 | 5 | 0.120 |
Why?
|
| Pregnancy | 4 | 2005 | 2331 | 0.120 |
Why?
|
| Genetic Complementation Test | 2 | 2004 | 35 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 3 | 2004 | 5 | 0.110 |
Why?
|
| Endothelial Cells | 3 | 2015 | 384 | 0.110 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2012 | 1 | 0.110 |
Why?
|
| Apolipoprotein B-100 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 268 | 0.110 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 2002 | 5 | 0.110 |
Why?
|
| Ileum | 2 | 2011 | 28 | 0.110 |
Why?
|
| Enterocytes | 2 | 2011 | 7 | 0.110 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 49 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2012 | 9 | 0.110 |
Why?
|
| Lipolysis | 1 | 2012 | 13 | 0.110 |
Why?
|
| Dietary Fats | 2 | 2012 | 103 | 0.110 |
Why?
|
| Lovastatin | 1 | 2012 | 78 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2012 | 110 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 1992 | 43 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2004 | 3 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 2 | 2004 | 4 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 132 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2012 | 617 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2012 | 62 | 0.100 |
Why?
|
| Cell Survival | 3 | 2009 | 901 | 0.100 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 337 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2012 | 222 | 0.100 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2010 | 7 | 0.100 |
Why?
|
| Isoflurane | 1 | 2010 | 16 | 0.100 |
Why?
|
| Anesthetics, Inhalation | 1 | 2010 | 21 | 0.100 |
Why?
|
| Zebrafish | 2 | 2002 | 187 | 0.100 |
Why?
|
| Hepatitis C | 1 | 2012 | 114 | 0.090 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 22 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2010 | 20 | 0.090 |
Why?
|
| Rats | 1 | 2018 | 5300 | 0.090 |
Why?
|
| Biliary Tract | 1 | 2010 | 17 | 0.090 |
Why?
|
| Culture Media | 1 | 2010 | 155 | 0.090 |
Why?
|
| Cell Count | 2 | 2011 | 248 | 0.090 |
Why?
|
| Kupffer Cells | 1 | 2010 | 75 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2007 | 172 | 0.090 |
Why?
|
| Mesoderm | 4 | 2006 | 231 | 0.090 |
Why?
|
| RNA Interference | 2 | 2009 | 266 | 0.090 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2009 | 21 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.090 |
Why?
|
| Kidney | 1 | 1994 | 945 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 53 | 0.090 |
Why?
|
| Body Patterning | 2 | 2001 | 44 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 1082 | 0.090 |
Why?
|
| Tretinoin | 2 | 2010 | 92 | 0.090 |
Why?
|
| Tunicamycin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2012 | 384 | 0.080 |
Why?
|
| Embryonic Development | 2 | 2006 | 100 | 0.080 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2008 | 3 | 0.080 |
Why?
|
| Organ Size | 1 | 2009 | 242 | 0.080 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2008 | 12 | 0.080 |
Why?
|
| Cholesterol, Dietary | 1 | 2008 | 22 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 137 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 110 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 181 | 0.080 |
Why?
|
| Nervous System | 2 | 2006 | 45 | 0.080 |
Why?
|
| Oligonucleotides | 1 | 2008 | 34 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 138 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 320 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 189 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2007 | 155 | 0.080 |
Why?
|
| Psychopathology | 1 | 2007 | 29 | 0.080 |
Why?
|
| Tight Junctions | 1 | 2007 | 25 | 0.080 |
Why?
|
| Adherens Junctions | 1 | 2007 | 13 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2009 | 124 | 0.080 |
Why?
|
| Crime | 1 | 2007 | 53 | 0.080 |
Why?
|
| Iron | 1 | 2009 | 197 | 0.080 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 102 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 28 | 0.080 |
Why?
|
| Skin | 1 | 2010 | 451 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2004 | 63 | 0.070 |
Why?
|
| Time Factors | 4 | 2013 | 4655 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 2 | 2004 | 2 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 66 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 56 | 0.070 |
Why?
|
| Intercellular Junctions | 1 | 2006 | 32 | 0.070 |
Why?
|
| Goblet Cells | 1 | 2006 | 9 | 0.070 |
Why?
|
| Ventricular Myosins | 2 | 2006 | 7 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2007 | 182 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2009 | 277 | 0.070 |
Why?
|
| Lipase | 1 | 2006 | 16 | 0.070 |
Why?
|
| Apolipoproteins | 2 | 2011 | 51 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 127 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2006 | 102 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2010 | 311 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1849 | 0.070 |
Why?
|
| Regeneration | 1 | 2006 | 105 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2009 | 631 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 204 | 0.070 |
Why?
|
| Cardiovascular System | 1 | 2006 | 85 | 0.070 |
Why?
|
| Homeodomain Proteins | 2 | 2004 | 157 | 0.070 |
Why?
|
| Violence | 1 | 2007 | 275 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 1753 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 579 | 0.060 |
Why?
|
| Genes, Reporter | 3 | 2006 | 191 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2005 | 96 | 0.060 |
Why?
|
| Fetus | 1 | 2005 | 157 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 120 | 0.060 |
Why?
|
| Hypoxia | 1 | 2005 | 169 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 160 | 0.060 |
Why?
|
| Protein Binding | 1 | 2007 | 1027 | 0.060 |
Why?
|
| Liver Glycogen | 1 | 2003 | 10 | 0.060 |
Why?
|
| Retroviridae | 1 | 2003 | 29 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 492 | 0.060 |
Why?
|
| Epithelium | 1 | 2003 | 172 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 196 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 160 | 0.060 |
Why?
|
| Embryonic Induction | 1 | 2003 | 19 | 0.060 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 13 | 0.060 |
Why?
|
| Xenobiotics | 1 | 2003 | 17 | 0.060 |
Why?
|
| COS Cells | 2 | 2006 | 155 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 696 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2008 | 659 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2002 | 64 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 447 | 0.050 |
Why?
|
| Muscle Development | 1 | 2022 | 31 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2005 | 16 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2002 | 137 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 282 | 0.050 |
Why?
|
| Chick Embryo | 1 | 2003 | 379 | 0.050 |
Why?
|
| Islets of Langerhans | 2 | 2005 | 87 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2022 | 117 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 498 | 0.050 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2022 | 40 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 78 | 0.050 |
Why?
|
| Hypertriglyceridemia | 2 | 2012 | 21 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2002 | 89 | 0.050 |
Why?
|
| Georgia | 1 | 2002 | 161 | 0.050 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2001 | 1 | 0.050 |
Why?
|
| Vertebrates | 1 | 2001 | 20 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 16 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 1026 | 0.050 |
Why?
|
| Homeostasis | 3 | 2010 | 291 | 0.050 |
Why?
|
| Genes, Homeobox | 1 | 2001 | 15 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 51 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 95 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2022 | 144 | 0.050 |
Why?
|
| Gestational Age | 3 | 2012 | 389 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 807 | 0.050 |
Why?
|
| Neomycin | 1 | 2001 | 56 | 0.050 |
Why?
|
| Adult | 4 | 2008 | 21375 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 230 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2001 | 223 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 188 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2000 | 28 | 0.050 |
Why?
|
| Apoptosis | 2 | 2006 | 1640 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2000 | 147 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2014 | 246 | 0.040 |
Why?
|
| Adolescent | 1 | 2012 | 8903 | 0.040 |
Why?
|
| Viral Nonstructural Proteins | 1 | 1999 | 16 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2004 | 596 | 0.040 |
Why?
|
| RNA Probes | 1 | 1998 | 15 | 0.040 |
Why?
|
| Clone Cells | 1 | 1998 | 67 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 144 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 1999 | 532 | 0.040 |
Why?
|
| Binding Sites | 2 | 2012 | 631 | 0.040 |
Why?
|
| Feeding and Eating Disorders | 1 | 1999 | 106 | 0.040 |
Why?
|
| Abetalipoproteinemia | 1 | 2017 | 1 | 0.040 |
Why?
|
| Tangier Disease | 1 | 2017 | 1 | 0.040 |
Why?
|
| Biological Transport | 1 | 1997 | 210 | 0.040 |
Why?
|
| Angiopoietin-like Proteins | 1 | 2017 | 2 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1999 | 85 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2017 | 35 | 0.040 |
Why?
|
| Apolipoprotein A-I | 1 | 2017 | 29 | 0.040 |
Why?
|
| Administration, Intranasal | 2 | 1999 | 88 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 1997 | 35 | 0.040 |
Why?
|
| Aging | 1 | 2003 | 911 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 226 | 0.040 |
Why?
|
| Gene Editing | 1 | 2017 | 33 | 0.040 |
Why?
|
| Potassium Channels | 1 | 1997 | 55 | 0.040 |
Why?
|
| Anencephaly | 1 | 1996 | 2 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 1997 | 86 | 0.040 |
Why?
|
| Neural Tube Defects | 1 | 1996 | 27 | 0.040 |
Why?
|
| Myosin Heavy Chains | 2 | 2006 | 49 | 0.040 |
Why?
|
| Cerebellum | 1 | 1997 | 103 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 166 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 186 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 231 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1998 | 682 | 0.030 |
Why?
|
| Lac Operon | 2 | 2006 | 54 | 0.030 |
Why?
|
| Cholesterol | 1 | 2017 | 331 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 2006 | 88 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 164 | 0.030 |
Why?
|
| Virulence | 2 | 1992 | 51 | 0.030 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2014 | 15 | 0.030 |
Why?
|
| DNA, Viral | 2 | 1992 | 114 | 0.030 |
Why?
|
| Blood Cells | 1 | 2014 | 27 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 282 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 78 | 0.030 |
Why?
|
| Seizures | 1 | 1997 | 279 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2014 | 131 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 627 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2007 | 1199 | 0.030 |
Why?
|
| DNA Primers | 3 | 2003 | 302 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2014 | 168 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2005 | 1085 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2007 | 237 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 116 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 235 | 0.030 |
Why?
|
| Carboxypeptidases A | 1 | 2012 | 2 | 0.030 |
Why?
|
| Yolk Sac | 2 | 2006 | 10 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2012 | 1 | 0.030 |
Why?
|
| Vaccinia | 1 | 1992 | 9 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 11 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 1992 | 10 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 58 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 44 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 35 | 0.030 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2012 | 35 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 420 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 38 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 411 | 0.030 |
Why?
|
| Hemostasis | 1 | 2012 | 32 | 0.030 |
Why?
|
| DNA Ligases | 1 | 1991 | 6 | 0.030 |
Why?
|
| Mutagens | 1 | 1991 | 18 | 0.030 |
Why?
|
| Lectins | 1 | 1992 | 81 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 86 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 397 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1992 | 159 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 196 | 0.030 |
Why?
|
| Graft Survival | 1 | 2014 | 465 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1992 | 358 | 0.030 |
Why?
|
| Apolipoprotein C-II | 1 | 2011 | 2 | 0.030 |
Why?
|
| Apolipoprotein A-V | 1 | 2011 | 2 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1992 | 75 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Apolipoproteins A | 1 | 2011 | 10 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2012 | 97 | 0.030 |
Why?
|
| Paneth Cells | 1 | 2011 | 2 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2011 | 15 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 284 | 0.020 |
Why?
|
| Duodenum | 1 | 2011 | 47 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 2077 | 0.020 |
Why?
|
| KATP Channels | 1 | 2010 | 1 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1992 | 362 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2356 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2011 | 57 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 765 | 0.020 |
Why?
|
| Microdissection | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 158 | 0.020 |
Why?
|
| DNA Damage | 1 | 1991 | 190 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 290 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2010 | 10 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 53 | 0.020 |
Why?
|
| Response Elements | 1 | 2010 | 29 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2010 | 200 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 23 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 42 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 383 | 0.020 |
Why?
|
| Hepcidins | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 106 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 258 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2002 | 7264 | 0.020 |
Why?
|
| Histones | 1 | 2010 | 111 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 82 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 301 | 0.020 |
Why?
|
| Middle Aged | 2 | 2009 | 21119 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2009 | 156 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2010 | 192 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2009 | 289 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 499 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 284 | 0.020 |
Why?
|
| Classification | 1 | 2007 | 8 | 0.020 |
Why?
|
| Exercise Test | 1 | 2009 | 242 | 0.020 |
Why?
|
| Hindlimb | 1 | 2007 | 38 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 384 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 201 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2006 | 1 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2006 | 87 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 2006 | 33 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2006 | 144 | 0.020 |
Why?
|
| COUP Transcription Factor II | 1 | 2006 | 1 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 58 | 0.020 |
Why?
|
| Albumins | 1 | 2006 | 72 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 219 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2010 | 718 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2006 | 54 | 0.020 |
Why?
|
| Heterozygote | 1 | 2006 | 174 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2006 | 136 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 69 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 196 | 0.020 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2005 | 3 | 0.020 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 9 | 0.020 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2005 | 10 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2005 | 10 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2005 | 24 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2005 | 23 | 0.020 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2005 | 18 | 0.020 |
Why?
|
| Glyburide | 1 | 2005 | 19 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2005 | 75 | 0.020 |
Why?
|
| Dogs | 2 | 1999 | 490 | 0.020 |
Why?
|
| Aorta | 1 | 2006 | 316 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 71 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 493 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2005 | 99 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 282 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2004 | 11 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2010 | 1447 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2004 | 165 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 302 | 0.010 |
Why?
|
| Child | 1 | 2014 | 6400 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 481 | 0.010 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2003 | 22 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 60 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 118 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1070 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 361 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 852 | 0.010 |
Why?
|
| Heart Failure | 1 | 2010 | 1179 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 929 | 0.010 |
Why?
|
| Wasting Syndrome | 1 | 1999 | 3 | 0.010 |
Why?
|
| Starvation | 1 | 1999 | 8 | 0.010 |
Why?
|
| Vero Cells | 1 | 1999 | 13 | 0.010 |
Why?
|
| Octoxynol | 1 | 1999 | 19 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 12 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1999 | 21 | 0.010 |
Why?
|
| Genome, Viral | 1 | 1999 | 14 | 0.010 |
Why?
|
| Virion | 1 | 1999 | 31 | 0.010 |
Why?
|
| Death | 1 | 1999 | 38 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1998 | 9 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1999 | 72 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 48 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 181 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 509 | 0.010 |
Why?
|
| Prealbumin | 1 | 1998 | 25 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 149 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 396 | 0.010 |
Why?
|
| Intestines | 1 | 1998 | 114 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1999 | 523 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1999 | 224 | 0.010 |
Why?
|
| GATA5 Transcription Factor | 1 | 1997 | 6 | 0.010 |
Why?
|
| Pentylenetetrazole | 1 | 1997 | 10 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1997 | 23 | 0.010 |
Why?
|
| GABA Antagonists | 1 | 1997 | 22 | 0.010 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1997 | 8 | 0.010 |
Why?
|
| Point Mutation | 1 | 1997 | 97 | 0.010 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 6 | 0.010 |
Why?
|
| Chimera | 1 | 1996 | 33 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1997 | 173 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1996 | 270 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1996 | 216 | 0.010 |
Why?
|
| United States | 1 | 2007 | 7335 | 0.010 |
Why?
|
| Endocytosis | 1 | 1994 | 113 | 0.010 |
Why?
|
| Cell Death | 1 | 1994 | 329 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1991 | 23 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 67 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 2175 | 0.000 |
Why?
|